For dialysis patients, high scores on a new fatigue rating scale predict an increased risk of heart attack or other cardiovascular events, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN)…

Diabetes UK’s Measure Up Roadshow 2010 kicked off this month and will be touring the country until the end of October in a bid to help people find out more about Type 2 diabetes and its risk factors. It has encouraged thousands of people in the UK to measure their waists and find out if they are at risk of developing Type 2 diabetes…

Widely used biomarkers are not optimal in early detection of liver cancer, the third most common cause of cancer-related death worldwide, according to a new study published in this month’s Gastroenterology. Two biomarkers used to complement ultrasound in the early detection of hepatocellular carcinoma, or liver cancer, are not ideal, according to Anna S. Lok, M.D…

Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for VPRIV, a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of Type 1 Gaucher disease in pediatric and adult patients…

As part of John Muir Health’s Minimally Invasive Thoracic Surgery program, a minimally invasive thymectomy - removal of the thymus gland - was successfully performed recently at the John Muir Medical Center - Concord Campus…

We are calling fundraisers from all over the South East to don their running shoes and race the 10 mile Great South Run, on Sunday 24th October, around the historic town of Portsmouth to help raise funds for diabetes research. We are offering guaranteed places in this fast growing European road race for all Diabetes UK recruits…

More and more reports have been surfacing about weight-loss surgery “curing” type 2 diabetes. At the same time, more and more questions are being asked about this process, how it works, who it works for, and how long it may continue to work…

On March 1, the first eye patients will enter an innovative new $132 million facility that expands the University of Michigan Health System’s capacity for eye care, research and education, and unites diabetes researchers as they work to accelerate the search for a cure and prevention of diabetes. The Brehm Tower at the W.K…

A new report examines and makes recommendations about the issue of self-monitoring of blood glucose (SMBG) in people with Type 2 diabetes who are not treated with insulin. The report was commissioned by the National Clinical Director for Diabetes in England. An NHS Diabetes working group was established with relevant stakeholders to undertake it, and they have now published their report…

Working with mice, Johns Hopkins scientists who tested drugs intended to halt growth of brain cancer stem cells a small population of cells within tumors that perpetuate cancer growth conclude that blocking these cells may be somewhat effective, but more than one targeted drug attack may be needed to get the job done…